RU94020400A - INDOL DERIVATIVES, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION, HEADACHE TREATMENT METHOD - Google Patents

INDOL DERIVATIVES, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION, HEADACHE TREATMENT METHOD

Info

Publication number
RU94020400A
RU94020400A RU94020400/04A RU94020400A RU94020400A RU 94020400 A RU94020400 A RU 94020400A RU 94020400/04 A RU94020400/04 A RU 94020400/04A RU 94020400 A RU94020400 A RU 94020400A RU 94020400 A RU94020400 A RU 94020400A
Authority
RU
Russia
Prior art keywords
production
pharmaceutical composition
headache treatment
treatment method
indol derivatives
Prior art date
Application number
RU94020400/04A
Other languages
Russian (ru)
Other versions
RU2117667C1 (en
Inventor
Фернандес Форнер Долорс
Пуиг Дуран Карлес
Прьето Сото Хосе
Вега Новерола Армандо
Морагуес Маури Хасинто
Original Assignee
Лабораториос Алмиралл С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929216009A external-priority patent/GB9216009D0/en
Application filed by Лабораториос Алмиралл С.А. filed Critical Лабораториос Алмиралл С.А.
Publication of RU94020400A publication Critical patent/RU94020400A/en
Application granted granted Critical
Publication of RU2117667C1 publication Critical patent/RU2117667C1/en

Links

Claims (1)

Соединение формулы (I)
Figure 00000001

где R1 и R2 каждый представляет водород или алкильную группу, Z представляет кольцо, выбранное из:
Figure 00000002

в котором n представляет 4, 5 или 6,
Figure 00000003

Figure 00000004

в котором R3 представляет водород или алкильную группу и R4 представляет алкильную, метокси, бензильную или R5 NHCO группу, в которой R5 представляет алкильную группу,
Figure 00000005

в котором R6 представляет алкильную группу, и его фармацевтически приемлемые соли, полезные для лечения мигрени и других заболеваний. Эти соединения получают декарбоксилированием соответствующей индолил 2-карбоновой кислоты.
The compound of formula (I)
Figure 00000001

where R 1 and R 2 each represents hydrogen or an alkyl group, Z represents a ring selected from:
Figure 00000002

in which n represents 4, 5 or 6,
Figure 00000003

Figure 00000004

in which R 3 represents hydrogen or an alkyl group and R 4 represents an alkyl, methoxy, benzyl or R 5 NHCO group, in which R 5 represents an alkyl group,
Figure 00000005

in which R 6 represents an alkyl group, and its pharmaceutically acceptable salts, useful for the treatment of migraine and other diseases. These compounds are obtained by decarboxylation of the corresponding indolyl 2-carboxylic acid.
RU94020400A 1992-07-28 1993-07-19 Indole derivatives, method of their synthesis, pharmaceutical composition showing selective binding activity with respect to 5--htid receptors and vasoconstrictive effect associated with 5-htid agonistic effect and a method of selective binding 5--htid receptors or agonistic effect on 5-htid receptors RU2117667C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9216009.2 1992-07-28
GB929216009A GB9216009D0 (en) 1992-07-28 1992-07-28 New indol derivatives

Publications (2)

Publication Number Publication Date
RU94020400A true RU94020400A (en) 1995-11-10
RU2117667C1 RU2117667C1 (en) 1998-08-20

Family

ID=10719423

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94020400A RU2117667C1 (en) 1992-07-28 1993-07-19 Indole derivatives, method of their synthesis, pharmaceutical composition showing selective binding activity with respect to 5--htid receptors and vasoconstrictive effect associated with 5-htid agonistic effect and a method of selective binding 5--htid receptors or agonistic effect on 5-htid receptors

Country Status (33)

Country Link
US (1) US5565447A (en)
EP (1) EP0605697B1 (en)
JP (1) JP2716585B2 (en)
KR (1) KR100191830B1 (en)
CN (1) CN1035179C (en)
AT (1) ATE177080T1 (en)
BR (2) BR9305589A (en)
CA (1) CA2120028C (en)
CZ (1) CZ282659B6 (en)
DE (2) DE69323712T2 (en)
DK (1) DK0605697T3 (en)
EC (1) ECSP930953A (en)
EG (1) EG20340A (en)
FI (1) FI109998B (en)
GB (1) GB9216009D0 (en)
GR (1) GR3029915T3 (en)
HK (1) HK1011680A1 (en)
HU (2) HUT70518A (en)
IL (1) IL106387A (en)
LU (1) LU90758I2 (en)
MX (1) MX9304524A (en)
MY (1) MY113266A (en)
NL (1) NL300053I2 (en)
NO (1) NO180231C (en)
NZ (1) NZ254152A (en)
PL (1) PL174352B1 (en)
RU (1) RU2117667C1 (en)
SG (1) SG48708A1 (en)
TW (1) TW235297B (en)
UA (1) UA27818C2 (en)
UY (1) UY23624A1 (en)
WO (1) WO1994002460A1 (en)
ZA (1) ZA935316B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2712591B1 (en) * 1993-11-19 1996-02-09 Pf Medicament New arylpiperazines derived from indole, their preparation and their therapeutic use.
FR2731224B1 (en) * 1995-03-02 1997-05-30 Pf Medicament NOVEL BI-TRYPTAMINIC SULFONAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
GB9523462D0 (en) * 1995-11-16 1996-01-17 Merck Sharp & Dohme Therapeutic agents
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6204274B1 (en) 1998-04-29 2001-03-20 American Home Products Corporation Indolyl derivatives as serotonergic agents
US6310066B1 (en) 1998-04-29 2001-10-30 American Home Products Corp. Antipsychotic indolyl derivatives
US6066637A (en) * 1998-06-19 2000-05-23 American Home Products Corporation Indolyl derivatives as serotonergic agents
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
WO2006129190A1 (en) * 2005-06-03 2006-12-07 Glenmark Pharmaceuticals Limited Process for the preparation of almotriptan
US20070112055A1 (en) * 2005-09-30 2007-05-17 Glenmark Pharmaceuticals Limited Crystalline forms of almotriptan and processes for their preparation
DE102006027229A1 (en) * 2006-06-09 2007-12-20 Grünenthal GmbH 1,3-Disubstituted 4-methyl-1H-pyrrole-2-carboxylic acid amides and their use for the preparation of medicaments
JP2010507585A (en) * 2006-10-19 2010-03-11 オースペックス・ファーマシューティカルズ・インコーポレイテッド Substituted indole
TWI321616B (en) 2007-03-27 2010-03-11 Coretronic Corp Centrifugal blower
CZ302424B6 (en) * 2007-06-13 2011-05-11 Zentiva, A. S. Process for preparing almotriptan of high purity
EP2170824A1 (en) * 2007-08-02 2010-04-07 Generics Ýuk¨Limited Novel process
CN103724252A (en) * 2012-10-12 2014-04-16 苏州四同医药科技有限公司 Preparation method of almotriptan
EP3766483A1 (en) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Orodispersible powder composition comprising a triptan

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
GR79215B (en) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB2162532B (en) * 1984-08-04 1988-08-03 Ritchie Swanson John Decontaminant wash composition
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
DE19775091I2 (en) * 1990-06-07 2007-05-24 Astrazeneca Ab Therapeutic heterocyclic compounds

Similar Documents

Publication Publication Date Title
RU94020400A (en) INDOL DERIVATIVES, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION, HEADACHE TREATMENT METHOD
RU94019971A (en) 1,3-DIGIDRO-2N-IMIDAZO / 4,5-V / QUINOLIN-2-SHE DERIVATIVES AS AN INHIBITORS, PHOSPHODESTERRASES, METHOD OF THEIR RECEIVING, INTERMEDIATE FOR THEM, PHARMACEUTICAL COMPOSITION CHAPTER.
EA200100553A1 (en) SUBSTITUTED BICYCLIC DERIVATIVES, USEFUL AS ANTICATIVE AGENTS
EP0354777A3 (en) 3-(4-piperidine)-5-(2-sulfonylaminoethyl) indole derivatives
RU93058555A (en) Quinuclidine derivatives, a method for their production, a pharmaceutical composition, a method for the treatment or prevention
FI883744A0 (en) Process for the preparation of pharmaceutically useful indole derivatives
HUT48589A (en) Process for production of new derivatives of substituated n-/1-hydroxi-4-piperidinil/-benzamid
NL300053I1 (en) Indole derivatives for migraine treatment.
ATE88344T1 (en) KYNURENIC ACID DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES.
ES8505379A1 (en) Derivatives of dihydropyridine and production thereof.
RU94030470A (en) Derivatives of 1-(arylalkylaminoalkyl)-imidazole, method of their synthesis, pharmaceutical composition and a method of treatment
DE69330601T2 (en) SEROTON INERGIC ERGOLIN DERIVATIVES
ES8304977A1 (en) Tryptamine derivatives of thienyloxypropanol amines, process for their preparation, pharmaceutical compositions containing them and preparation of the latter.
RU2001116601A (en) NEW PYRIMIDINE DERIVATIVES AND METHODS FOR PRODUCING THEM
EP0311029A3 (en) Process for preparing 3,3-disubstituted indolines
EA200000922A1 (en) AMINOANTRACYCLINON DERIVATIVES AND THEIR APPLICATION IN THE TREATMENT OF AMYLOIDOSIS
RU94046382A (en) Agent affecting central nervous system, process for preparation thereof, and pharmaceutical composition containing said agent
RU93058275A (en) DERIVATIVES OF THIOPHEN-2-CARBONIC ACID, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PRODUCTION